ArticleAnnals of gastroenterological surgery2026
Prognostic and Predictive Role of Lymph Node Count in Stage II Colon Cancer: A Retrospective Analysis of a Japanese Nationwide Cohort.
Article in Annals of gastroenterological surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: This study aimed to reevaluate the prognostic significance of the number of harvested lymph nodes (LNs) and its predictive value for adjuvant chemotherapy (ACT) in stage II colon cancer (CC), considering tumor sidedness. Methods: Pathological stage II CC patients who underwent curative surgery with Japanese D3 lymphadenectomy were assessed using a Japanese database. The optimal cutoff for harvested LNs was evaluated by analyzing all cutoff values ( Results: A total of 3526 (left/right; 2684/842) pathological stage II CC patients were identified. A cutoff of 12LNs was identified as a prognostic factor for OS (HR 1.45; [95% CI: 1.15-1.82]). However, a stronger prognostic impact was observed with a cutoff of seven (HR 2.04; [1.44-2.88]). Subgroup analysis based on sidedness revealed variations in the optimal cutoff (7 for left-sided [HR 2.25; (1.54-3.280)]) and 10 for right-sided (HR 1.82; [1.02-3.26]). The survival benefit of ACT was not observed across all cutoffs. Conclusion: Although cutoffs other than 12 LNs demonstrated stronger prognostic value in certain subgroups, harvesting ≥ 12 LNs remained a consistent prognostic factor across sidedness. The number of harvested LNs may not be a useful predictive factor of ACT in stage II CC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.